Publications
92
Citations
1,527
Est. group size
~1
Recurring co-author estimate
Active years
16
Publishing since 2011
This researcher studies gastrointestinal cancers, especially colorectal, esophageal, and liver (hepatocellular) cancer, with a focus on prevention, early detection, and factors that affect who develops and survives these diseases. Work spans screening tests and biomarkers (such as blood-based tests and genetic risk scores), the possible cancer-preventive effects of common medications like metformin and aspirin, and how social and economic factors (such as neighborhood poverty) contribute to disparities in cancer outcomes.
Publication output grew substantially from 2017 through a peak in 2023, followed by a decline in 2024-2025, though the overall five-year average remains higher than the earlier years in the decade.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Impacts of Neighborhood Persistent Poverty and Socioeconomic Status on Hepatocellular Carcinoma Outcomes: A Large Population‐Based Cohort Study
Cancer Medicine · 2026
- Colorectal cancer screening blood test: awareness and willingness among a national sample of adults post-Federal and Drug Administration approval
BMC Public Health · 2025
- Perceptions of COVID-19 risk among individuals with preexisting health conditions
PLoS ONE · 2025
- Abstract 6328: Metformin induces cell cycle arrest and inhibits proliferation in <i>KRAS</i>-mutated colorectal cancer
Cancer Research · 2025
- Abstract 7359: Systemic chronic inflammation is associated with quality of life in the Cancer Disparities Research Network
Cancer Research · 2025
- Su1698: EVALUATING THE CLINICAL UTILITY OF POLYGENIC RISK SCORES IN HEPATOCELLULAR CARCINOMA RISK STRATIFICATION – A SYSTEMATIC REVIEW
Gastroenterology · 2025
- Abstract PR016: Supplement And Medication Use in Early-Onset Colorectal Cancer: An Analysis of the Ohio Colorectal Cancer Prevention Initiative
Clinical Cancer Research · 2025
- Neighborhood level socioeconomic disparities are associated with reduced colorectal cancer survival
Scientific Reports · 2025
- Association of metformin use and cancer incidence: a systematic review and meta-analysis
JNCI Journal of the National Cancer Institute · 2024
- The utility of liquid biopsy-based methylation biomarkers for colorectal cancer detection
Frontiers in Oncology · 2024
- Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome
JNCI Journal of the National Cancer Institute · 2024
- Atypical epithelioid trophoblastic lesion presenting as pseudocyst from the niche in the cesarean scar: A case report and review of the literature
European Journal of Obstetrics & Gynecology and Reproductive Biology · 2024
- Multi-cancer early detection tests: a strategy for improvement
BMJ Oncology · 2024
- Abstract 1445: Emergence of frameshift mutations during tumorigenesis in VCMsh2 mouse model of Lynch syndrome
Cancer Research · 2024
- Response to Khouri and Suissa
JNCI Journal of the National Cancer Institute · 2024
- Gastroenterology×9
- Cancer Research×6
- JNCI Journal of the National Cancer Institute×3
- JAMA Network Open×3
- JNCI Cancer Spectrum×3
- Urs von Holzen
Medicine · Indiana University
- Md Sazzad Hassan
Medicine · Indiana University
- Kelly R. Haisley
Medicine · The Ohio State University
- Thomas J. Birdas
Medicine · Indiana University
- Gary D. Stoner
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile